All News Pfizer, Inc.

Equities

PFE

US7170811035

Market Closed - Nyse Other stock markets 04:00:04 2024-04-30 pm EDT			After market 04:31:45 pm
25.62 ^USD	-0.08%		25.62	-0.02%

05:18pm	Pfizer, Genmab Say FDA Approves Tivak to Treat Cervical Cancer	MT
03:27pm	A flurry of corporate results ahead of the Fed's rate decision

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pfizer : Goes Live in SXSW’s Podcast Lounge	01:09pm	PU
Pfizer, Genmab Say FDA Approves Tivak to Treat Cervical Cancer	11:18am	MT
A flurry of corporate results ahead of the Fed's rate decision	09:27am
Sensodyne maker Haleon to shut UK factory with loss of 435 jobs	08:52am	AN
Genmab, Pfizer Win US FDA Approval for Cervical Cancer Treatment	11:55pm	MT
TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer	06:41pm	BU
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer	06:41pm	BU
Pfizer Inc. and Genmab A/S Announce FDA Grants Full Approval for TIVDAK to Treat Recurrent or Metastatic Cervical Cancer	06:40pm	CI
J&J, Bristol Myers lose challenges to US drug price negotiation program	Apr. 29	RE
Pfizer, Genmab Get Full FDA Approval for Cervical-Cancer Drug	Apr. 29	DJ
Tesla Rally Boosts S&P 500, Nasdaq; This Week's Earnings, Fed Decision in Focus	Apr. 29	MT
Equity Markets Rise With Key Earnings, Fed Decision in Focus	Apr. 29	MT
US FDA grants full approval for Pfizer's cervical cancer drug	Apr. 29	RE
Equities Higher as Traders Await This Week's Key Earnings, Fed Decision	Apr. 29	MT
S&P 500 Companies' Latest Quarterly Results Mixed so Far, Oppenheimer Says	Apr. 29	MT
Equities Rise Intraday as Traders Await This Week's Key Earnings, Fed Decision	Apr. 29	MT
CAC40: limited downturn, despite the beginnings of a rate cut	Apr. 29	CF
Novel haemophilia B gene therapy approved	Apr. 29	AQ
CAC40: limited erosion, despite the beginnings of a rate cut	Apr. 29	CF
Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy	Apr. 29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Pfizer, Inc: A cycle for nothing?

December 14, 2023 at 10:58 am EST

Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs

October 31, 2023 at 04:50 pm EDT